These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8726009)

  • 41. Inducible clindamycin resistance in Staphylococcus aureus: a cross-sectional report.
    Rahbar M; Hajia M
    Pak J Biol Sci; 2007 Jan; 10(1):189-92. PubMed ID: 19070014
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The postantibiotic effect induced by antimicrobial combinations.
    Gudmundsson S; Erlendsdóttir H; Gottfredsson M; Gudmundsson A
    Scand J Infect Dis Suppl; 1990; 74():80-93. PubMed ID: 2129068
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Increasing Clindamycin and Trimethoprim-Sulfamethoxazole Resistance in Pediatric Staphylococcus aureus Infections.
    Khamash DF; Voskertchian A; Tamma PD; Akinboyo IC; Carroll KC; Milstone AM
    J Pediatric Infect Dis Soc; 2019 Sep; 8(4):351-353. PubMed ID: 30011009
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vitro postantibiotic effect and postantibiotic leukocyte enhancement of tobramycin.
    Novelli A; Mazzei T; Fallani S; Cassetta MI; Conti S
    J Chemother; 1995 Aug; 7(4):355-62. PubMed ID: 8568546
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacodynamics of beta-lactam antibiotics. Studies on the paradoxical and postantibiotic effects in vitro and in an animal model.
    Odenholt-Tornqvist I
    Scand J Infect Dis Suppl; 1989; 58():1-55. PubMed ID: 2499924
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dalbavancin in-vitro activity obtained against Gram-positive clinical isolates causing bone and joint infections in US and European hospitals (2011-2016).
    Pfaller MA; Flamm RK; Castanheira M; Sader HS; Mendes RE
    Int J Antimicrob Agents; 2018 Apr; 51(4):608-611. PubMed ID: 29277526
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The postantibiotic effect of fusidic acid against gram-positive bacteria.
    Munckhof WJ; Turnidge JD
    J Antimicrob Chemother; 1997 Sep; 40(3):433-6. PubMed ID: 9338499
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clindamycin-resistance in methicillin-resistant Staphylococcus aureus isolated from animals.
    Rich M; Deighton L; Roberts L
    Vet Microbiol; 2005 Dec; 111(3-4):237-40. PubMed ID: 16289541
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Postantibiotic effect of ciprofloxacin compared with that of five other quinolones.
    Minguez F; Ramos C; Barrientos S; Loscos A; Prieto J
    Chemotherapy; 1991; 37(6):420-5. PubMed ID: 1760941
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Antibacterial activity of clindamycin and lincomycin in broth, serum, and in combination with polymorphonuclear leukocytes against Staphylococcus aureus and Staphylococcus epidermidis].
    Bassler M; Just HM; Richter A; Zeller H; Daschner F
    Infection; 1984; 12(4):280-5. PubMed ID: 6490174
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Post-antibiotic effects of RP 59500 with Staphylococcus aureus.
    Nougayrede A; Berthaud N; Bouanchaud DH
    J Antimicrob Chemother; 1992 Jul; 30 Suppl A():101-6. PubMed ID: 1399941
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sitafloxacin (DU-6859a) and trovafloxacin: postantibiotic effect and in vitro interactions with rifampin on methicillin-resistant Staphylococcus aureus.
    Giamarellou-Bourboulis EJ; Sambatakou H; Grecka P; Chryssouli Z; Giamarellou H
    Diagn Microbiol Infect Dis; 1999 Aug; 34(4):301-7. PubMed ID: 10459481
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clindamycin versus nafcillin or methicillin in the treatment of Staphylococcus aureus osteomyelitis in children.
    Kaplan SL; Mason EO; Feigin RD
    South Med J; 1982 Feb; 75(2):138-42. PubMed ID: 7036354
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy of clindamycin in the treatment of Staphylococcus aureus osteomyelitis in dogs.
    Braden TD; Johnson CA; Wakenell P; Tvedten HW; Mostosky UV
    J Am Vet Med Assoc; 1988 Jun; 192(12):1721-5. PubMed ID: 3410788
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact of pH and cationic supplementation on in vitro postantibiotic effect.
    Gudmundsson A; Erlendsdottir H; Gottfredsson M; Gudmundsson S
    Antimicrob Agents Chemother; 1991 Dec; 35(12):2617-24. PubMed ID: 1810197
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inducible resistance to clindamycin in Staphylococcus aureus: validation of Vitek-2 against CLSI D-test.
    Gardiner BJ; Grayson ML; Wood GM
    Pathology; 2013 Feb; 45(2):181-4. PubMed ID: 23277176
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacokinetic interaction between rifampicin and clindamycin in staphylococcal osteoarticular infections.
    Goulenok T; Seurat J; Selle A; Jullien V; Leflon-Guibout V; Grall N; Lescure FX; Lepeule R; Bertrand J; Fantin B; Burdet C; Lefort A
    Int J Antimicrob Agents; 2023 Aug; 62(2):106885. PubMed ID: 37302771
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Incidence of clindamycin resistance in clinical isolates of Staphylococcus aureus.
    Debdas D; Joshi S
    J Infect Dev Ctries; 2011 Apr; 5(4):316-7. PubMed ID: 21537077
    [No Abstract]   [Full Text] [Related]  

  • 59. In-vitro postantibiotic effects of miocamycin and erythromycin on gram-positive cocci.
    Varotto F; Garlaschi ML; Garlaschi MC; Falchi M; Scaglione F; Cattaneo G; De Luca M; Fraschini F
    J Chemother; 1990 Dec; 2(6):355-61. PubMed ID: 2093106
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [In vitro activity of linezolid, moxifloxacin, levofloxacin, clindamycin and rifampin, alone and in combination, against Staphylococcus aureus and Staphylococcus epidermidis].
    Soriano A; Jurado A; Marco F; Almela M; Ortega M; Mensa J
    Rev Esp Quimioter; 2005 Jun; 18(2):168-72. PubMed ID: 16130039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.